InvestorsHub Logo
Followers 22
Posts 3693
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Thursday, 12/20/2018 8:32:18 PM

Thursday, December 20, 2018 8:32:18 PM

Post# of 20689
More, more & more dilution coming --

To Our Stockholders:

NOTICE IS HEREBY GIVEN that a Special Meeting of Stockholders (the "Special Meeting") of Momenta Pharmaceuticals, Inc. (the "Company") will be held on Wednesday, January 30, 2019, at 9:00 a.m., Eastern time, at the offices of Latham & Watkins LLP, 200 Clarendon Street, Boston, Massachusetts 02116. At the Special Meeting, stockholders will consider and vote on the following matters:

1.
the amendment of the Company's Third Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock of the Company from 100,000,000 to 200,000,000;


....we do not have sufficient authorized shares available to settle all of our currently outstanding equity awards or to grant new equity awards under our incentive compensation plans up to the full number of shares available under the plans. Therefore, our board of directors believes it is in the best interests of the Company and our stockholders to increase our authorized shares of Common Stock in order to have additional shares available for use as our board of directors deems appropriate or necessary, including having shares available to settle our outstanding equity awards and to grant new equity awards using shares authorized under our incentive plans. As such, the primary purpose of the Share Increase Amendment is to provide the Company with greater flexibility with respect to managing its Common Stock in connection with such corporate purposes as may, from time to time, be considered.

Read more or don't read more:

https://ih.advfn.com/stock-market/NASDAQ/momenta-MNTA/stock-news/78933526/proxy-statement-notice-of-shareholders-meeting-p#A2237402ZPRE14A_HTM_BG40501_TABLE_OF_CONTENTS